MANAGEMENT OF ENDOCRINE DISEASE: Growth and growth hormone therapy in short children born preterm
نویسندگان
چکیده
منابع مشابه
Growth of short children born small for gestational age and their response to growth hormone therapy.
Growth hormone [GH] is licensed for use in children born small for gestational age (SGA) who fail to catch-up. We retrospectively compared the response of twenty children born SGA (who satisfied the auxological criteria) to growth hormone (Group I) versus randomly selected age and sex matched controls from a group of SGA children with growth related complaints, not treated with GH (Group II). A...
متن کامل[Growth of preterm-born children].
Children born prematurely might experience a period of growth restriction just after birth. Catch-up growth begins during the first months of life and can be slow and progressive. These children may remain shorter and thinner throughout infancy and childhood compared to children born at term. In some cases, complete catch-up growth occurs only during adolescence. However, some children do not c...
متن کاملGrowth of preterm born children.
BACKGROUND In this review, we describe the growth of (very) preterm infants or (very) low-birth-weight infants from birth until adulthood. METHODS A systematic analysis of growth of these infants is thwarted by different definitions (classification by gestational age or birth weight) used in the literature. RESULTS The early postnatal period of these individuals is almost invariably charact...
متن کاملGrowth Hormone Therapy for Short Children Born Small for Gestational Age
Children born small for gestational age may demonstrate continued growth retardation, resulting in persistent short stature. In the majority of the cases, this is linked with abnormal growth hormone secretion and also abnormal insulinlike growth factor levels. This review discusses the treatment of such children with recombinant human growth hormone. It illustrates the importance of starting th...
متن کاملReduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.
OBJECTIVES To examine the influence of recombinant human growth hormone (rhGH) therapy on insulin sensitivity in short children born small for gestational age (SGA). STUDY DESIGN Twelve short (height standard deviation score, -3.2 +/- 0.1) non-GH-deficient children SGA (7 boys/5 girls) were studied at 9.3 +/- 1.0 years of age. The insulin sensitivity index was measured with Bergman's minimal ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Endocrinology
سال: 2017
ISSN: 0804-4643,1479-683X
DOI: 10.1530/eje-16-0482